Electra Therapeutics, Inc. (ETRA) stock
ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$8.35+0.04 (+0.48%)
Close on Nov 17, 2026Market cap $524.94MP/E –Yield –
Electra Therapeutics cash
Cash and short-term investments held at the end of each period.
Electra Therapeutics's cash was $402.50M at Sep 30, 2026. For fiscal 2025 it was $86.52M.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $86.52M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $402.50M | – |
| Q4 FY2025 | Dec 31, 2025 | $86.52M | – |
See a number that looks wrong?